An expert discusses the latest guidelines to reduce brain injury in adults who are comatose after cardiac resuscitation.
Studies suggest that magnesium, riboflavin, butterbur, coenzyme Q10, and certain nutraceutical combinations may have efficacy in preventing migraine. This slideshow reviews the evidence.
Botox for episodic migraine? Vitamin B for migraine with aura? Best option for acute cluster headache? Take the quiz.
An update on responsive neurostimulation, the only implantable, closed-loop device approved for treating seizures.
Math capabilities of children with autism may be on par with those of typically developing children, but not so with language.
There appears to be a bidirectional relationship between migraine and depression, in which one disorder increases the risk for the other and vice versa.
Exenatide, a GLP-1 agonist, has been shown to protect neurons. The authors of two small studies of this agent's effects on motor function in Parkinson disease discuss the evidence here.
How common is psychosis in PD? Implications? Risk factors? Insights here, and measures that may help.
3 things you may not know—from the new AAN guidelines—about sudden unexpected death in epilepsy.
Key details about an option for the treatment of drug-resistant epilepsy in patients who are not surgical candidates.
Two new studies shed light on risk factors for stroke and MI, and a third suggests neurologic use s for Zolpidem that don’t involve treating insomnia.
Many physicians want it, many patients are asking for it. Here’s a look at the pros and cons—and the case for expanded coverage of telemedicine.
What do these images suggest is the cause of bilateral lower limb symptoms of 4 months’ duration?
Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.
OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.